H. F. pEF Shunt System: 3-Year Safety & Function 03/13/26
Welcome to Cardiology Today â Recorded March 13, 2026. This episode summarizes 5 key cardiology studies on topics like left atrial pressure and left atrial shunting. Key takeaway: H. F. pEF Shunt System: 3-Year Safety & Function.
Article Links:
Article 1: Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial. (Heart (British Cardiac Society))
Article 2: Analysis and prediction of cardiovascular research hotspots, trends and interdisciplinarity. (Heart (British Cardiac Society))
Article 3: Electrocardiogram abnormalities and cardiovascular risk prediction in older Chinese: the Guangzhou Biobank Cohort Study. (Heart (British Cardiac Society))
Article 4: Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications. (Heart (British Cardiac Society))
Article 5: The ALT FLOW Early Feasibility Study 3-year Results Assessing Left Atrial to Coronary Sinus Shunting in HFpEF. (ESC heart failure)
Full episode page: https://podcast.explainheart.com/podcast/h-f-pef-shunt-system-3-year-safety-function-03-13-26/
đ Featured Articles
Article 1: Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40930594
Summary: The EPIC-CAD trial defined specific patient populations with atrial fibrillation and stable coronary artery disease receiving edoxaban antithrombotic therapy. This study investigated the clinical outcomes associated with off-label underdosing of direct oral anticoagulants in this patient cohort. Participants were randomized to either edoxaban monotherapy or a dual antithrombotic therapy regimen combining edoxaban with a single antiplatelet agent. This research therefore characterizes the comparative safety and efficacy of these two distinct antithrombotic strategies.
Article 2: Analysis and prediction of cardiovascular research hotspots, trends and interdisciplinarity.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40877031
Summary: This study systematically analyzed over 2 million 512 445 cardiovascular publications to characterize research topics, trends, and interdisciplinarity. Artificial intelligence techniques, including natural language processing, were extensively utilized to extract and cluster text fragments from titles and abstracts. This comprehensive data processing approach provides a foundation for clarifying recent cardiovascular research directions and informs policy development for the academic community.
Article 3: Electrocardiogram abnormalities and cardiovascular risk prediction in older Chinese: the Guangzhou Biobank Cohort Study.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40866119
Summary: This study characterized electrocardiogram abnormalities in 26846 Chinese individuals aged 50 and older from the Guangzhou Biobank Cohort Study. Participants had no cardiovascular disease at baseline. Minor and major electrocardiogram abnormalities were classified based on the Minnesota Code Manual, allowing for definitive categorization of severity. Severity was specifically defined as normal, one minor, two or more minor, or major.
Article 4: Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications.
Journal: Heart (British Cardiac Society)
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/40664496
Summary: This study performed a retrospective assessment of sudden cardiac death incidence in patients with atrial fibrillation over an 11-year period, from 2007 to 2018. The analysis included individuals undergoing coronary angiography, specifically those with suspected or known coronary artery disease referred for elective angiography. The study also encompassed patients presenting with acute coronary syndrome, characterizing the long-term sudden cardiac death risk within these specific patient cohorts.
Article 5: The ALT FLOW Early Feasibility Study 3-year Results Assessing Left Atrial to Coronary Sinus Shunting in HFpEF.
Journal: ESC heart failure
PubMed Link: https://pubmed.ncbi.nlm.nih.gov/41814577
Summary: The ALT-FLOW Early Feasibility Study assessed device safety, patency, and echocardiographic parameters over three years in patients with heart failure with preserved ejection fraction. The study specifically evaluated symptoms, health status, and exercise capacity in 95 patients who had a left ventricular ejection fraction greater than 40 percent. This research therefore characterizes the long-term performance of the A. P. T. U. R. E. transcatheter shunt system for left atrial to coronary sinus shunting.
đ Transcript
Today’s date is March 13, 2026. Welcome to Cardiology Today. Here are the latest research findings.
Article number one. Off-label underdosing of edoxaban antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease: findings from the EPIC-CAD trial. The EPIC-CAD trial defined specific patient populations with atrial fibrillation and stable coronary artery disease receiving edoxaban antithrombotic therapy. This study investigated the clinical outcomes associated with off-label underdosing of direct oral anticoagulants in this patient cohort. Participants were randomized to either edoxaban monotherapy or a dual antithrombotic therapy regimen combining edoxaban with a single antiplatelet agent. This research therefore characterizes the comparative safety and efficacy of these two distinct antithrombotic strategies.
Article number two. Analysis and prediction of cardiovascular research hotspots, trends and interdisciplinarity. This study systematically analyzed over 2 million 512 445 cardiovascular publications to characterize research topics, trends, and interdisciplinarity. Artificial intelligence techniques, including natural language processing, were extensively utilized to extract and cluster text fragments from titles and abstracts. This comprehensive data processing approach provides a foundation for clarifying recent cardiovascular research directions and informs policy development for the academic community.
Article number three. Electrocardiogram abnormalities and cardiovascular risk prediction in older Chinese: the Guangzhou Biobank Cohort Study. This study characterized electrocardiogram abnormalities in 26846 Chinese individuals aged 50 and older from the Guangzhou Biobank Cohort Study. Participants had no cardiovascular disease at baseline. Minor and major electrocardiogram abnormalities were classified based on the Minnesota Code Manual, allowing for definitive categorization of severity. Severity was specifically defined as normal, one minor, two or more minor, or major.
Article number four. Atrial fibrillation and the risk of sudden cardiac death: incidence, impact and implications. This study performed a retrospective assessment of sudden cardiac death incidence in patients with atrial fibrillation over an 11-year period, from 2007 to 2018. The analysis included individuals undergoing coronary angiography, specifically those with suspected or known coronary artery disease referred for elective angiography. The study also encompassed patients presenting with acute coronary syndrome, characterizing the long-term sudden cardiac death risk within these specific patient cohorts.
Article number five. The ALT FLOW Early Feasibility Study 3-year Results Assessing Left Atrial to Coronary Sinus Shunting in Heart Failure with Preserved Ejection Fraction. The ALT-FLOW Early Feasibility Study assessed device safety, patency, and echocardiographic parameters over three years in patients with heart failure with preserved ejection fraction. The study specifically evaluated symptoms, health status, and exercise capacity in 95 patients who had a left ventricular ejection fraction greater than 40 percent. This research therefore characterizes the long-term performance of the A. P. T. U. R. E. transcatheter shunt system for left atrial to coronary sinus shunting.
Thank you for listening. Don’t forget to subscribe.
đ Keywords
left atrial pressure, left atrial shunting, research trends, electrocardiogram abnormalities, antithrombotic therapy, heart failure with preserved ejection fraction, atrial fibrillation, edoxaban, direct oral anticoagulants, A. P. T. U. R. E. system, cardiovascular risk, sudden cardiac death, Minnesota Code Manual, Guangzhou Biobank Cohort Study, coronary angiography, transcatheter shunt, acute coronary syndrome, artificial intelligence, cardiovascular research, older populations, coronary artery disease, natural language processing, bibliometrics.
âšī¸ About
Concise summaries of cardiovascular research for professionals.
Subscribe âĸ Share âĸ Follow